This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Surgical Oncology  • Immunology  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Umberto Baccarani, MD; Brendan J. Carroll, MD; Jonathan R. Hiatt, MD; Annibale Donini, MD; Giovanni Terrosu, MD; Robert Decker, MD; Mudjianto Chandra, MD; Fabrizio Bresadola, MD; Edward H. Phillips, MD

Arch Surg. 1998;133:517-522.

Background  Staging laparotomy provides useful information for management of Hodgkin disease but has fallen into disfavor because procedure-related morbidity exceeds that of new chemotherapeutic regimens.

Objective  To determine the feasibility, effectiveness, and safety of laparoscopic staging for Hodgkin disease compared with those of open staging.

Patients  Fifty-five patients with Hodgkin disease of cell types including nodular sclerosis in 43 (78%), mixed cellularity in 9 (16%), and lymphocyte predominance in 3 (5%).

Study Design  Concurrent evaluation of laparoscopic staging (n=15) and retrospective review of open staging (n=40).

Interventions  Laparoscopic and open techniques of surgical staging for Hodgkin disease, including splenectomy, liver biopsies, and lymph node sampling.

Main Outcome Measures  Operative time, duration of postoperative ileus and of postoperative hospitalization, morbidity, number of lymph nodes retrieved, alteration in pathologic stage, recurrence, and survival.

Results  For laparoscopic staging vs open staging groups, mean operative time was 202 vs 144 minutes (P=.001); mean postoperative ileus was 1.9 vs 3.2 days (P<.001); mean postoperative hospitalization was 4.4 vs 6.7 days (P<.001); complications occurred in 3 patients (20%) vs 11 patients (28%) (P=.57); and mean number of lymph nodes retrieved was 8.5 vs 4.6 (P=.05). In the laparoscopic staging group, 2 cases (13%) were upstaged and 2 cases (13%) were downstaged. In the open staging group, 6 cases (15%) were upstaged and 3 cases (7.5%) were downstaged. Follow-up data were available for all patients in the laparoscopic staging group, at a mean of 23.5 months postoperatively. All were alive, none had recurrent disease below the diaphragm, and 2 (13%) had residual mediastinal disease. Follow-up data were available for 31 patients (78%) in the open staging group at a mean of 52.5 months postoperatively. All were alive, 27 (87%) were disease free, 3 (10%) had had relapses above the diaphragm, and 1 (3%) had residual mediastinal disease.

Conclusions  Compared with open staging, laparoscopic staging of Hodgkin disease is oncologically equivalent and functionally superior. These data should encourage reappraisal of the role of operative staging in the management of Hodgkin disease.

From the Departments of Surgery (Drs Carroll, Hiatt, Chandra, and Phillips) and Hematology-Oncology (Dr Decker), Cedars-Sinai Medical Center, Los Angeles, Calif; and Departments of Surgery, University of Udine, Udine, Italy (Drs Baccarani, Donini, Terrosu, and Bresadola), and UCLA School of Medicine, Los Angeles (Dr Hiatt).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?